Angola

About the cervical cancer vaccine:

Studies carried out in several countries have shown that the vaccine significantly reduces the risk of developing precancerous lesions and cervical cancer. The vaccine is also widely recommended by world health organisations. The World Health Organisation (WHO) has pre-qualified six vaccines for large-scale use, which means that these vaccines meet strict safety and efficacy standards. Since 2006, safe and highly effective vaccines have been available to prevent infection and protect women against cervical cancer. By 2021, 20 African countries had successfully incorporated the cervical cancer vaccine into their immunisation programmes.

Copyright European Union, 1995-2024

SOURCE European Investment Bank